Healthcare - Biotechnology - NASDAQ - US
$ 12.41
-7.94 %
$ 129 M
Market Cap
0.13
P/E
Price Target
Average
182.03%
Revenue Forecast
Estimate
--2.97%
EBIT
Estimate
48.06%
Net Income
Estimate
64.62%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Avalo Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for AVTX of $35 , with forecasts ranging from a low of $35 to a high of $35 .
AVTX Lowest Price Target
Wall Street Target
35 USD
182.03%
AVTX Average Price Target
Wall Street Target
35 USD
182.03%
AVTX Highest Price Target
Wall Street Target
35 USD
182.03%
REVENUE FORECAST
Revenue Forecast Chart AVTX
EBIT FORECAST
EBIT Forecast Chart AVTX
NET INCOME FORECAST
Net Income Chart AVTX